| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Outline of Final Research Achievements |
Radical surgery for patients with head and neck cancer often causes major dysfunctions, such as dysphagia, dysarthria, or mastication disorder, leading to impaired quality of life. Here, a new magnetic anticancer drug has been developed. This drug has two characteristics; anti-cancer effect and hyperthermic effect in combination with an alternating current magnetic field (ACMF). We have evaluated the anti-cancer effects of a new magnetic anticancer drug using oral cancer cells in vitro.The results in this study demonstrated the unique property of the novel magnetic anticancer compound. In particular, this drug had anti-cancer effect with heat induction in an ACMF. This drug may thus be useful in a novel cancer therapy in the future.
|
